Mechanical Thrombectomy in the Middle East and North Africa: Interim Results from the MEMENTO Registry
Launched by MIDDLE EAST NORTH AFRICA STROKE AND INTERVENTIONAL NEUROTHERAPIES ORGANIZATION · Nov 22, 2024
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Detailed Description Stroke is a leading cause of morbidity and mortality worldwide, with a significant burden in the MENA region due to limited access to advanced stroke care therapies like mechanical thrombectomy (MT). The MEMENTO Registry seeks to collect real-world data on MT practices, outcomes, and accessibility in the MENA region to inform clinical practice and policy. The study includes AIS patients who underwent MT for confirmed LVO or medium vessel occlusion (MeVO), with or without prior intravenous thrombolysis (IV tPA), regardless of age, baseline NIHSS score, or time from sympt...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 years and older (no upper age limit). Diagnosed with acute ischemic stroke due to confirmed large vessel occlusion (LVO) or medium vessel occlusion (MeVO).
- • Underwent mechanical thrombectomy (MT) with or without prior intravenous thrombolysis (IV tPA).
- • Pre-stroke modified Rankin Scale (mRS) score of 0-5. Consent to participate in the registry (by patient or legal representative).
- Exclusion Criteria:
- • Absence of confirmed LVO or MeVO. Pre-stroke mRS score of 6. Known severe comorbid conditions precluding MT. Inability to obtain informed consent. Patients not treated with MT.
About Middle East North Africa Stroke And Interventional Neurotherapies Organization
The Middle East North Africa Stroke and Interventional Neurotherapies Organization (MENA-SINO) is a leading clinical trial sponsor dedicated to advancing the field of stroke management and interventional neurotherapies across the MENA region. Committed to improving patient outcomes, MENA-SINO collaborates with healthcare professionals, researchers, and institutions to conduct innovative clinical trials that address critical gaps in stroke treatment and prevention. By fostering a multidisciplinary approach and leveraging regional expertise, the organization aims to enhance clinical practices, promote evidence-based medicine, and ultimately contribute to the global body of knowledge in neurovascular health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, , Egypt
Patients applied
Trial Officials
ossama yassin MANSOUR, MD, PhD,
Principal Investigator
Alexandria University
farouk Hassan, MD,Phd
Principal Investigator
cairo university, Egypt
Atila Oscan Ozdimar, MD, PhD
Principal Investigator
Eskisehir Osmangazi University
Syed Irteza Hussain, MD
Principal Investigator
Cleveland Clinic Abu Dhabi
Faisal Alghamdi, MD
Principal Investigator
King Abdullah Medical City
Nadia Hammami, MD
Principal Investigator
institut National de Neurologie
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported